[Federal Register: April 29, 1999 (Volume 64, Number 82)]
[Notices]               
[Page 23087]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29ap99-60]


[[Page 23087]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Radiological Devices Panel of the Medical Devices Advisory 
Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.

    Name of Committee: Radiological Devices Panel of the Medical 
Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on May 17, 1999, 9 a.m. to 
5:30 p.m.
    Location: Corporate Bldg., conference rm. 020B, 9200 Corporate 
Blvd., Rockville, MD.
    Contact Person: Robert J. Doyle, Center for Devices and 
Radiological Health (HFZ-470), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-594-1212, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12526. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will discuss bone strength assessment, with a 
focus on the use of gender-specific and race-specific data bases in 
assessing fracture risk and their applicability to bone densitometry 
and sonometry device labeling.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by May 6, 1999. 
Oral presentations from the public will be scheduled between 
approximately 9:45 a.m. and 10:15 a.m., and for an additional 30 
minutes near the end of the committee deliberations. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before May 6, 1999, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On May 17, 1999, from 12:15 p.m. to 
12:45 p.m., the meeting will be closed to the public to permit 
discussion and review of trade secret and/or confidential commercial 
information (5 U.S.C. 552b(c)(4)) relating to present and future agency 
issues.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 23, 1999.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 99-10695 Filed 4-28-99; 8:45 am]
BILLING CODE 4160-01-F